GDC-0980 5 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × GDC-0980
IC-87114 10 mg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × IC-87114
IC-87114 5 mg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × IC-87114
IC-87114 1 mg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × IC-87114
IPI-145 10 mg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × IPI-145
CAL101 10 mg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × CAL101
BKM120 1 mg | ≥98% LKT Laboratories, Inc. PI3K inhibitor, microtubule polymerization inhibitor. More Information Supplier Page × BKM120
Istradefylline 100 mg | ≥98% LKT Laboratories, Inc. Adenosine A2A antagonist. More Information Supplier Page × Istradefylline
Istradefylline 25 mg | ≥98% LKT Laboratories, Inc. Adenosine A2A antagonist. More Information Supplier Page × Istradefylline
Istradefylline 5 mg | ≥98% LKT Laboratories, Inc. Adenosine A2A antagonist. More Information Supplier Page × Istradefylline
